Medtronic

2198 articles with Medtronic

• Medtronic CEO Geoff Martha to Speak at Morgan Stanley Global Healthcare Conference

  9/11/2020

  Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the Morgan Stanley 18th Annual Global Healthcare Conference on Monday, September 14, 2020.

• Medtronic Study Finds Opioid-Induced Respiratory Depression in the Hospital More Common and Costly

  9/10/2020

  PRODIGY Study Provides First Validated Risk Prediction Tool to Guide Continuous Monitoring for Opioid-Induced Respiratory Depression (OIRD) OIRD Occurred in 46% of Patients Studied Patients with Respiratory Depression Are 37% More Likely to Experience an Adverse Event and Require Longer Hospital Stays DUBLIN , Sept. 10, 2020 /PRNewswire/ -- Medtronic plc (NYSE:

• Medtronic EVP & CFO Karen L. Parkhill To Participate in the Wells Fargo Securities 2020 Virtual Healthcare Conference

  9/4/2020

  Medtronic plc  (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Wells Fargo Securities 2020 Virtual Healthcare Conference on Thursday, September 10, 2020 . Karen Parkhill , executive vice president and chief financial officer of Medtronic, will answer questions about the company begin

• Medtronic Announces FDA Approval for MiniMed™ 770G Insulin Pump System with Smartphone Connectivity for People with Type 1 Diabetes

  9/1/2020

  Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its MiniMed™ 770G hybrid closed loop system.

• Medtronic Cryoablation Superior to Drug Therapy for Symptomatic Paroxysmal Atrial Fibrillation

  8/29/2020

  ESC Congress: New Research Highlights First-Line Use of Cryoablation as Highly Effective, and with Improved Quality of Life Scores

• Medtronic Reports First Quarter 2020 Financial Results

  8/25/2020

  Medtronic plc announced financial results for its first quarter of fiscal year 2021, which ended July 31, 2020.

• Medtronic Board Appoints Kevin Lofton as a New Director

  8/24/2020

  Medtronic plc announced that its Board of Directors appointed Kevin Lofton to the Board as an independent director, effective September 15, 2020.

• Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2021

  8/24/2020

  The board of directors of Medtronic plc on Friday, August 21, 2020, approved the fiscal year 2021 second quarter cash dividend of $0.58 per ordinary share, representing a 7 percent increase over the prior year.

• Medtronic Evolut TAVR System Receives Updated U.S. Labeling Revising Precaution for Treatment of Low-Risk Patients with Bicuspid Aortic Stenosis

  8/21/2020

  Revised Commercial Labeling Broadens Patient Population Who May be Candidates for Transcatheter Aortic Valve Replacement

• Medtronic Begins Post-Market, Real-World Study of the InterStim™ Micro System

  8/20/2020

  ELITE Study Designed to Confirm Long-Term Safety, Efficacy and Patient Benefit of Sacral Neuromodulation with the InterStim™ Micro System for Treatment of Overactive Bladder, Fecal Incontinence and Non-Obstructive Urinary Retention DUBLIN, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has begun recruitment of the prospective, multicenter, global, post-market study of the InterStim™ Micro system for sacral neuromodula

• Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 2021

  8/11/2020

  Medtronic plc (NYSE:MDT) announced today that it will report financial results for its first quarter of fiscal year 2021 on Tuesday, August 25, 2020. A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at  http://newsroom.medtronic.com . The news release will include summary financial information for the company’s first quarter of fiscal year 2021, which ended on Friday, July 31, 2020. Medtroni

• Medtronic to Acquire Smart Insulin Pen Company Companion Medical

  8/11/2020

  Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the planned acquisition of privately-held Companion Medical, manufacturer of InPen — the only U.S. FDA-cleared smart insulin pen system paired with an integrated diabetes management app on the market. The addition of Companion Medical’s In

• Medtronic Announces Comprehensive U.S. Launch of New InterStim™ Micro Neurostimulator

  8/5/2020

  First Patient Receives New Sacral Neuromodulation Device Implant at Cleveland Clinic

• Medtronic Expands Leadership in Treating Bladder and Bowel Control Conditions with Two New FDA-Approved Products: InterStim™ Micro Neurostimulator and InterStim™ SureScan™ MRI Leads

  8/3/2020

  World’s Smallest Rechargeable Bladder/Bowel Control System — InterStim Micro — Features Trusted MRI Technology for Full-Body 1.5 and 3 Tesla MRI Scans

• Medtronic to Acquire Medicrea

  7/15/2020

  Medtronic Will Become the First Company to Offer an Integrated Solution Including Artificial Intelligence-Driven Surgical Planning, Personalized Spinal Implants and Robotic Assisted Surgery

• Blackstone Announces $4.6 Billion Final Close of Life Sciences Fund

  7/9/2020

  Blackstone Life Sciences has already invested and committed nearly $1 billion from this fund over the past three months, demonstrating strong demand for the strategy

• Medtronic and Tandem Diabetes Care Enter Into Patent Cross-License Agreement

  7/9/2020

  Medtronic plc (NYSE:MDT) and Tandem Diabetes Care, Inc. (NASDAQ:TNDM) today announced that they have entered into a non-exclusive patent cross-license agreement for certain technologies in the field of diabetes. Cross-licensing each other’s patent portfolios enables both companies to focus on helping people with diabetes through innovation of future products and services, while avoiding the distraction of potential

• Medtronic Introduces MiniMed™ Mio™ Advance Infusion Set Enabling Fewer Insertion Steps for People with Diabetes in the U.S.

  7/7/2020

  Medtronic plc  (NYSE:MDT), the global leader in medical technology, today introduced the MiniMed™ Mio™ Advance infusion set to all Medtronic insulin pump customers in the United States. The MiniMed Mio Advance infusion set is the newest addition to the MiniMed™ portfolio of infusion sets and gives people using insulin pumps an optimal user experience with fewer steps 1 . The MiniMed Mio Advance infusion set is inserted in only four steps — individ

• Medtronic Gains FDA Clearance, CE Mark for LINQ II™ Insertable Cardiac Monitor (ICM)

  7/7/2020

  Next Generation ICM Offers Remote Programming with Improved Longevity and Enhanced Accuracy DUBLIN, July 07, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) clearance and CE ( Conformité Européenne ) Mark approval for its LINQ II™ insertable cardiac monitor (ICM) with remote programming, which enables clinicians to optimize device settings without the need for patients to ret

• Medtronic Begins Real-World Post-Market Study of the Valiant Navion Thoracic Stent Graft System in Patients with Thoracic Aortic Dissection

  7/6/2020

  Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the start of a prospective, observational, global, multi-center, real-world, post-market study to evaluate the safety and effectiveness of the Valiant Navion™ Thoracic Stent Graft System in the treatment of thoracic aort